IGC Pharma (IGC) Non-cash Items (2012 - 2018)

IGC Pharma (IGC) reported Non-cash Items of $105884.0 for Q1 2018, down 18.58% quarter-over-quarter from $130045.0 in Q3 2016.

IGC Pharma (IGC) Non-cash Items (2012 - 2018) Analysis & Trends

IGC Pharma (IGC) has 4 years of Non-cash Items data on file, last reported at $105884.0 in Q1 2018.

Non-cash Items for Q1 2018 came in at $105884.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was $105884.0 (changed N/A YoY), and the FY2018 annual result was $105884.0, changed N/A from the prior year.
Non-cash Items eased to $105884.0 in Q1 2018 per IGC's latest filing, from $130045.0 in the prior quarter.
Over five years, Non-cash Items peaked at $130045.0 in Q2 2015 and troughed at $105884.0 in Q1 2018.
A 3-year average of $125212.8 and a median of $130045.0 in 2015 frame the typical range for Non-cash Items.
On a YoY basis, Non-cash Items climbed as much as 0.0% in 2016 and fell as far as 0.0% in 2016.
A 3-year view of Non-cash Items shows it stood at $130045.0 in 2015, then changed by 0.0% to $130045.0 in 2016, then decreased by 18.58% to $105884.0 in 2018.
Business Quant data shows IGC's Non-cash Items at $105884.0 in Q1 2018, $130045.0 in Q3 2016, and $130045.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	IGC Pharma	29.33 Mn	29.07 Mn	-

Download Data